High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.
Saved in:
| Title: | High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo. |
|---|---|
| Authors: | Mundle ST; Discovery North America, Sanofi Pasteur, Cambridge, Massachusetts, United States of America. sophia.mundle@sanofipasteur.com, Hernandez H, Hamberger J, Catalan J, Zhou C, Stegalkina S, Tiffany A, Kleanthous H, Delagrave S, Anderson SF |
| Source: | PloS one [PLoS One] 2013; Vol. 8 (2), pp. e57224. Date of Electronic Publication: 2013 Feb 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
